<!DOCTYPE html><html lang="en"><head><meta charset="UTF-8"/><meta name="viewport" content="width=device-width, initial-scale=1.0"/><title>Discharge Summary - MAPIMS</title><style>:root { --primary-color: #004a99; --secondary-color: #003366; --accent-color: #e6f0fa; --border-color: #d1d9e6; --text-dark: #2c3e50; --text-muted: #546e7a;
}
@page { size: A4; margin: 0; }
body { font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif; margin: 0; padding: 0; background-color: #f5f7f9; color: var(--text-dark); line-height: 1.4; font-size: 10pt; -webkit-print-color-adjust: exact;
}
.container { width: 210mm; margin: 20px auto; background-color: #fff; padding: 20mm; box-shadow: 0 0 10px rgba(0,0,0,0.1); box-sizing: border-box;
}
@media print { body { background-color: #fff; } .container { margin: 0; box-shadow: none; width: 210mm; padding: 15mm 20mm 10mm 20mm; } .no-print { display: none; } .new-page-section { break-before: page; padding-top: 15mm; } section, table, .info-group, .diagnosis-box, .signature-area { break-inside: avoid; } .report-title { margin-top: 10mm; }
}
.hospital-header { display: flex; align-items: center; border-bottom: 3px solid var(--primary-color); padding-bottom: 10px; margin-bottom: 20px;
}
.logo { flex: 0 0 120px; }
.logo img { max-width: 100%; height: auto; }
.hospital-details { flex: 1; padding-left: 20px; }
.hospital-details h1 { margin: 0; font-size: 20pt; color: var(--primary-color); text-transform: uppercase; }
.hospital-details p { margin: 2px 0; font-size: 9pt; color: var(--text-muted); }
.report-title { text-align: center; background-color: var(--accent-color); padding: 10px; margin-bottom: 20px; border-radius: 4px;
}
.report-title h2 { margin: 0; font-size: 14pt; color: var(--secondary-color); letter-spacing: 1px; }
.info-grid { display: grid; grid-template-columns: 1fr 1fr; gap: 15px; margin-bottom: 20px; }
.info-group { border: 1px solid var(--border-color); border-radius: 4px; padding: 10px; }
.info-group-title { font-weight: bold; font-size: 9pt; color: var(--primary-color); text-transform: uppercase; margin-bottom: 8px; border-bottom: 1px solid var(--border-color); padding-bottom: 4px;
}
.info-row { display: flex; margin-bottom: 4px; }
.info-label { flex: 0 0 120px; font-weight: 600; color: var(--text-muted); font-size: 8.5pt; }
.info-value { flex: 1; font-size: 9pt; }
.section-title { background-color: var(--secondary-color); color: white; padding: 6px 12px; font-size: 11pt; margin-top: 15px; margin-bottom: 10px; border-radius: 2px; text-transform: uppercase;
}
.content-text { text-align: justify; margin-bottom: 15px; }
.diagnosis-box { background-color: #fafafa; border: 1px dashed var(--border-color); padding: 10px 20px; margin-bottom: 15px;
}
table { width: 100%; border-collapse: collapse; margin: 15px 0; }
th { background-color: #f0f4f8; color: var(--secondary-color); font-weight: 600; text-align: left; padding: 10px; border: 1px solid var(--border-color); font-size: 9pt;
}
td { padding: 8px 10px; border: 1px solid var(--border-color); font-size: 9pt; }
tr:nth-child(even) { background-color: #fcfcfc; }
.footer { margin-top: 40px; padding-top: 15px; border-top: 1px solid var(--border-color); text-align: center; font-size: 8pt; color: var(--text-muted);
}
.signature-area { margin-top: 40px; display: flex; justify-content: space-between; break-inside: avoid; }
.sig-box { text-align: center; width: 200px; }
.sig-line { border-top: 1px solid var(--text-dark); margin-bottom: 5px; }
ul { padding-left: 20px; margin: 5px 0; }
.lab-results { font-size: 8.5pt; }</style></head><body><div class="container"><header class="hospital-header"><div class="logo"><img src="https://mh.mapims.edu.in/static/images/logo.png" alt="MAPIMS Logo" onerror="this.src='https://via.placeholder.com/120x60?text=MAPIMS+LOGO'"></div><div class="hospital-details"><h1>MAPIMS</h1><p>Melmaruvathur Adhiparasakthi Institute of Medical Sciences and Research</p><p>Melmaruvathur, Kancheepuram Dist, Tamil Nadu - 603319</p><p>Contact: +91-44-27529401 | Email: info@mapims.edu.in</p></div></header><div class="report-title"><h2>HOSPITAL DISCHARGE SUMMARY</h2></div><div class="info-grid"><div class="info-group"><div class="info-group-title">Patient Profile</div><div class="info-row"><span class="info-label">Name:</span><span class="info-value">Rajesh Kumar</span></div><div class="info-row"><span class="info-label">UHID / IP No:</span><span class="info-value">UH2001 / IP3001</span></div><div class="info-row"><span class="info-label">Age / Gender:</span><span class="info-value">58 / Male</span></div><div class="info-row"><span class="info-label">Address:</span><span class="info-value">No 45, Gandhi Road, Melmaruvathur, Tamil Nadu 603319</span></div></div><div class="info-group"><div class="info-group-title">Admission Details</div><div class="info-row"><span class="info-label">Admission Date:</span><span class="info-value">2026-01-28</span></div><div class="info-row"><span class="info-label">Discharge Date:</span><span class="info-value">2026-02-05</span></div><div class="info-row"><span class="info-label">Consultant:</span><span class="info-value">Dr. P. Arumugam, MD, DM (Cardiology)</span></div><div class="info-row"><span class="info-label">Ward / Bed:</span><span class="info-value">ICCU / Bed 3</span></div></div></div><section><div class="section-title">Clinical Summary</div><div class="content-text"><p><strong>Reason for Admission:</strong> Mr. Rajesh Kumar, a 58-year-old male, was admitted with complaints of acute coronary syndrome. Patient presented with severe retrosternal chest pain and breathlessness. ECG showed ST elevation in V1–V4.</p><p><strong>Clinical Examination:</strong> On admission, the patient was tachypneic with a RR of 26/min. Pulse was 112/min, feeble but regular. BP was 160/90 mmHg. Cardiovascular examination revealed a prominent S3 gallop. Respiratory examination showed bilateral basal fine inspiratory rales. Pitting pedal edema was present up to the mid-calf level.</p></div><div class="section-title">Significant Findings &amp; Examination</div><div class="content-text"><p>Systemic Review: The patient is a known diabetic and hypertensive for the past 8 years. Previously on oral hypoglycemic agents but had stopped them 3 months ago. CNS within normal limits. Abdominal examination showed mild tenderness in the right hypochondrium (congestive hepatomegaly).</p><p>Vital Signs Summary: Throughout the hospital stay, blood pressure fluctuated between 130/80 and 160/100 mmHg. Post-diuretic therapy, heart rate stabilized around 74-80/min. SpO2 improved from 90% (Admission) to 99% (Discharge) on room air.</p></div></section><section class="new-page-section"><div class="section-title">Laboratory Investigations</div><table class="lab-results"><thead><tr><th>Investigation</th><th>Result (Admission)</th><th>Result (Discharge)</th><th>Reference Range</th></tr></thead><tbody><tr><td>Hemoglobin</td><td>12.1 g/dL</td><td>12.4 g/dL</td><td>13 - 17 g/dL</td></tr><tr><td>Total WBC Count</td><td>12,400 /cu.mm</td><td>7,800 /cu.mm</td><td>4,000 - 11,000</td></tr><tr><td>Serum Creatinine</td><td>1.8 mg/dL</td><td>1.2 mg/dL</td><td>0.7 - 1.3 mg/dL</td></tr><tr><td>Blood Urea</td><td>52 mg/dL</td><td>34 mg/dL</td><td>10 - 45 mg/dL</td></tr><tr><td>Serum Sodium</td><td>134 mEq/L</td><td>140 mEq/L</td><td>135 - 145 mEq/L</td></tr><tr><td>Serum Potassium</td><td>3.6 mEq/L</td><td>4.5 mEq/L</td><td>3.5 - 5.1 mEq/L</td></tr><tr><td>Troponin I</td><td>28.5 ng/mL</td><td>1.2 ng/mL</td><td>&lt; 0.04 ng/mL</td></tr><tr><td>NT-proBNP</td><td>5,120 pg/mL</td><td>1,450 pg/mL</td><td>&lt; 125 pg/mL</td></tr><tr><td>HbA1c</td><td>9.2 %</td><td>-</td><td>&lt; 6.5%</td></tr><tr><td>Total Cholesterol</td><td>245 mg/dL</td><td>-</td><td>&lt; 200 mg/dL</td></tr></tbody></table><div class="section-title">Imaging &amp; Diagnostic Reports</div><div class="content-text"><p>Chest X-Ray (PA View): Cardiomegaly with cardiothoracic ratio of 58%. Pulmonary venous congestion and Kerley B lines suggestive of interstitial edema. Bilateral costophrenic angles blunted.</p><p>Electrocardiogram (ECG): Sinus tachycardia, Left Axis Deviation, Left Ventricular Hypertrophy with strain pattern.</p><p>2D Echocardiography: Dilated LV with global hypokinesia. LVEF 35%. Moderate Mitral Regurgitation. Grade II Diastolic Dysfunction.</p></div><div class="section-title">Final Diagnosis</div><div class="diagnosis-box"><p><strong>Primary Diagnosis:</strong> ST-elevation myocardial infarction (STEMI), post primary PCI (I21.3).</p><p style="margin-top: 10px; font-weight: bold; color: var(--primary-color);">Secondary Diagnoses / Provisional:</p><ul><li>Acute coronary syndrome</li></ul><p><strong>ICD-10 Codes:</strong></p><ul><li>I21.3</li><li>I25.10</li></ul></div></section><section class="new-page-section"><div class="section-title">Hospital Course &amp; Care Provided</div><div class="content-text"><p>Patient presented with severe retrosternal chest pain and breathlessness. ECG showed ST elevation in V1–V4. Emergency coronary angiography revealed critical LAD lesion; primary PCI with drug-eluting stent was performed. Post-procedure monitored in ICCU for 48 hours. Echo showed anterior wall hypokinesia with LVEF 40%. Started on dual antiplatelets, statin, ACE-i, beta-blocker. No recurrent chest pain or arrhythmia. Mobilised gradually and discharged on day 8.</p></div><div class="section-title">Procedures Performed</div><table><thead><tr><th>Date</th><th>Procedure Name</th><th>Indication &amp; Outcome</th></tr></thead><tbody><tr><td></td><td>Primary PCI – LAD stent (DES)</td><td></td></tr><tr><td></td><td>Right radial access</td><td></td></tr><tr><td></td><td>IV cannulation, Foley catheter (removed day 2)</td><td></td></tr></tbody></table><div class="section-title">Medical Devices / Implants</div><table><thead><tr><th>Device Type</th><th>Model / Serial No.</th><th>Location / Position</th><th>Implant Date</th></tr></thead><tbody><tr><td>Drug Eluting Stent (DES)</td><td>Xience Pro / SN-pending</td><td>LAD - Proximal/Mid Segment</td><td>2026-01-28</td></tr></tbody></table><div class="section-title">Condition at Discharge</div><div class="content-text"><p>Stable, ambulant, afebrile. No chest pain. BP and heart rate controlled.</p></div></section><section class="new-page-section"><div class="section-title">Post-Discharge Instructions</div><p style="font-weight: bold; margin-bottom: -10px;">Discharge Medications</p><table><thead><tr><th>Medication Name</th><th>Dosage</th><th>Frequency</th><th>Duration</th><th>Instructions</th></tr></thead><tbody><tr><td>Aspirin</td><td>150 mg OD,</td><td></td><td></td><td></td></tr><tr><td>Clopidogrel</td><td>75 mg OD,</td><td></td><td></td><td></td></tr><tr><td>Atorvastatin</td><td>40 mg ON,</td><td></td><td></td><td></td></tr><tr><td>Ramipril</td><td>2.5 mg OD,</td><td></td><td></td><td></td></tr><tr><td>Metoprolol</td><td>25 mg BD. Continue for 12 months then review.</td><td></td><td></td><td></td></tr></tbody></table><div class="section-title">Follow-up Advice</div><div class="content-text"><p>Cardiology OPD in 2 weeks with ECG and Echo. Earlier if chest pain or breathlessness.</p></div><div class="section-title">Urgent Care Instructions (Warning Signs)</div><div class="content-text"><p>Return immediately if chest pain, syncope, bleeding, or severe dyspnoea.</p></div><div class="section-title">Dietary and Activity Advice</div><div class="content-text"><p>Strict compliance with dual antiplatelets. Avoid heavy exertion for 6 weeks. Cardiac rehabilitation. Low-fat diet, salt restriction.</p></div><div class="signature-area"><div class="sig-box"><div class="sig-line"></div><p>Patient / Attendant Signature</p></div><div class="sig-box"><div class="sig-line"></div><p><strong>Dr. P. Arumugam, MD, DM (Cardiology)</strong></p><p>Cardiology</p></div></div><div class="footer"><p>This is a computer-generated summary from MAPIMS. Please correlate clinically.</p><p>&copy; 2026 Melmaruvathur Adhiparasakthi Institute of Medical Sciences and Research</p></div></section></div></body></html>